Pancreatic carcinoma remains one of the leading causes of cancer -related deaths in the world. In the years from 2000 to 2009, the incidence rate in the United States increased by 0.9% per year and the death rate increased by 0.5% per year.
Logiq 7 (Logiq 7, General Electric, Fairfield, Connecticut, United States), Hitachi EUB 6000, or Hitachi EUB 550 (Hitachi, Chiyoda, Tokyo, Japan) apparatus. All examinations were performed in the morning, and all patients were fasting on the day of the examination. Each examination was performed according to the established study protocol, including staging of pancreatic cancer. The T and N categories were established and analyzed according to the TNM Classification of Malignant Tumors. 8 The infiltration of the major abdominal vessels (the aorta, celiac artery, superior mesenteric artery, common hepatic artery, hepatic portal vein, superior mesenteric vein) was assessed with color Doppler and power Doppler ultrasonography. The ultrasound criteria of vascular invasion applied in this study were as follows: loss of normal hyperechogenic tissue between the tumor and the vessel, obstruction, or encasement by tumor tissue over more than half of the circumference of any vessel. The intraoperative finding of major artery infiltration, and, in most cases, also of major abdominal vein infiltration, precluded resection. Local lymph nodes were assessed as metastatic if they were hypoechogenic and the size of their short axis exceeded 10 mm. All examinations were conducted by surgeons who verified their findings intraoperatively and performed more than 1000 abdominal ultrasonographies per year.
The final staging of pancreatic carcinoma was based on a histopathological examination of surgical specimen in resectable cases and on the results of intraoperative surgical assessment.
The assessment of retrieved lymph nodes was performed in patients in whom resections had been performed and in some patients with unresectable tumors in whom lymph nodes had been collected intraoperatively for a histopathological study. CT was used to determine the nodal status when the tumor was not resected and lymph nodes were not retrieved.
In all patients, abdominal CT and chest X -ray were required to exclude distant metastases for clinical staging before surgery.
surgery None of the patients received neoadjuvant therapy prior to surgery. A Whipple or Traverso-Longmire procedure was used for tumors located in the head of the pancreas, a distal pancreatectomy for those located in the body or tail, and a total pancreatectomy for multifocal tumors. Regional lymph nodes were routinely resected en bloc with the tumor. We did not perform vascular resection with reconstruction. In patients who had a nonresectable tumor, exploratory laparotomy or gastroenteroanastomosis (or biliodigestive anastomosis in those with a tumor within the head of the pancreas) was performed (TAbLE 2) . A bilio digestive anastomosis was not performed if endoscopic biliary prosthesis was implemented before the surgery or planned after the surgery. reaches 90%. 5, 6 The limitations associated with abdominal ultrasound examination, such as insufficient experience of the operator, low quality of the ultrasound equipment, or incorrect patient preparation, result in divergent opinions on its efficacy in pancreatic cancer staging. A significant advantage of this modality is its ability to detect liver metastases, which makes further imaging unnecessary. Morrin et al. 7 demonstrated that grey -scale ultrasound combined with Doppler imaging has similar results to helical CT and CT angiography in detecting venous involvement.
The aim of our study was to assess the diagnostic accuracy of abdominal ultrasonography in staging of pancreatic carcinoma in all patients who underwent surgery between 2000 and 2012 in a tertiary care center. All examinations were performed by surgeons experienced in abdominal ultrasonography and the results were compared with intraoperative findings. We attempted to establish the role of abdominal ultrasonography performed by experienced diagnosticians in patients with pancreatic cancer.
PATIENTs ANd mEThOds Patient selection
The study involved 454 consecutive patients with pancreatic cancer admitted to a tertiary referral hospital, who underwent surgery between the years 2000 and 2012. The inclusion criteria were as follows: pancreatic cancer confirmed preoperatively by fine -needle aspiration biopsy or core -needle biopsy performed intraoperatively or by histological examination of the specimen; preoperative abdominal ultrasonography and CT; signed informed consent for diagnostic procedures and surgery. The exclusion criteria were as follows: distant metastases confirmed by imaging studies before surgery; lack of informed consent; contraindications for general anesthesia.
All relevant data were collected prospectively using a standard electronic database (Magic2, Magic Software Enterprises). The authors analyzed the following variables: clinical and pathological features, staging of pancreatic cancer based on preoperative abdominal ultrasonography, type of surgical procedures, pathomorphological staging and staging of pancreatic carcinoma based on intraoperative findings and CT.
The study was performed in accordance with the ethical standards of the Declaration of Helsinki and Good Clinical Practice. The approval of an ethics committee was not required to conduct the present study, according to the legal system in Poland.
diagnostic procedures Abdominal ultrasound examinations were performed in an outpatient clinic after patients with suspicion of pancreatic cancer had been consulted by a surgeon. After the ultrasound examination, patients were scheduled for CT, following which a decision on surgical treatment was made. The mean time between ultrasonography and surgery was 14 ±3.5 days. Ultrasound examinations were conducted using the GE and 245 men (54.0%). The final results of the staging process are summarized in TAbLE 1. Ultrasound scans and surgical specimens of cancer at different stages are presented in FIGuRE 1A-C. Radical resection (R0) was performed in 32.6% of the patients, while the R1 or R2 procedure in 19.6%. In the majority of the patients (47.8%), an unresectable tumor was found intraoperatively and the procedure was limited to palliative patency restoration or exploratory laparotomy (TAbLE 2) .
The diagnostic accuracy of abdominal ultrasonography in all patients was established as 85.6% for all T categories. The diagnostic accuracy for specific T categories is presented in TAbLE 3. The highest accuracy was observed for T1 and T2 tumors (91.1% and 95.7% respectively), while for more advanced lesions, the accuracy was lower: 85.4% for T3 and 81.7% for T4. Sensitivity, specificity, and negative and positive predictive values for specific T categories are presented in The diagnostic accuracy exceeding 94% was observed in patients with T1 and T2 lesions although those patients constituted the minority of those surgically treated at our department during the 12 years of study. For more advanced tumors (T3 and T4), the accuracy was lower but still above 80%. A relatively high accuracy for T1 and T2 lesions may result from the experience of sonographers. All examinations were conducted by surgeons who verified their findings intraoperatively and performed more than 1000 abdominal ultrasound examinations per year. Lower accuracy for T4 lesions probably resulted from difficulties in the assessment of vascular invasion on ultrasound examination. In our previous study summarizing the value of ultrasonography in 409 patients with pancreatic cancer, 19 higher accuracy was observed for T3 and T4 tumors (89.4% and 92.1%, respectively) but after analyzing the whole group of 454 patients, the results were less favorable. This confirms that even with a better quality of ultrasound equipment, it is still difficult to precisely determine the advanced stages of pancreatic carcinoma and its resectability. the value of abdominal ultrasonography for different locations of pancreatic cancer (head, body, or tail) because the TNM classification and resectability criteria are the same for all pancreatic cancers, and the majority of pancreatic cancers are located in the head of the pancreas.
In addition, we established the diagnostic accuracy of abdominal ultrasonography for detecting lymph node involvement and predicting the type of surgery. The accuracy was 66.1% (95% confidence interval [CI], 59.2-74.6) for detecting metastatic lymph nodes and 74.8% (95% CI, 66.2-80.4) for predicting the type of surgery. Resectability assessed by ultrasonography was 58.8% and the actual resectability was 52.2%.
dIsCussION diagnostic accuracy for establishing T categories The results of our study indicate that abdominal ultrasonography remains a relatively accurate diagnostic tool in patients with pancreatic carcinoma. The present study evaluated the diagnostic accuracy of ultrasound examination in establishing a T category of pancreatic cancer according to the TNM classification. 8 with angiography, which are currently being considered as having the highest diagnostic accuracy (94% to 100%). 3, 5, 26 High diagnostic accuracy of CT in solid tumors results from isotropic resolution (the same resolution in all dimensions), collimation allowing to obtain the layers of less than 1 mm in width, and multidetector imaging. 27 A few previous studies reported high sensitivity of abdominal ultrasonography (up to 94%). 28,29 As a consequence, this modality was recommended as the primary examination in cases with suspicion of pancreatic cancer. 11 The results of other studies suggested lower sensitivity of ultrasonography (below 70%) and recommended CT as the primary diagnostic modality. 30 These confounding findings probably result from restrictions in patient selection, small study groups, and different levels of experience in ultrasonography. The number of false-negative resultse on ultrasonography decreases if investigators may confirm their diagnosis intraoperatively. Therefore, the diagnostic accuracy of abdominal ultrasonography performed by surgeons should be higher, as observed in our study.
Lymph node involvement In our study, the lowest diagnostic accuracy of ultrasonography was observed for lymph node metastases (66.1%). Gorelick et al.
24 evaluated the accuracy of abdominal ultrasonography in assessing lymph node involvement to be 77%, while Sofuni et al. 20 and Bunk et al., 31 who used the color Doppler mode, reported a higher accuracy, namely, of 80% to 82.5%. Trede et al.
14 reported an accuracy of 76.6%. In contrast, Chen et al. 32 questioned the accuracy of a routine ultrasound examination for diagnosing lymph node metastases in patients with pancreatic cancer, reporting an accuracy of only 33%. Our results confirm that ultrasonography should not be regarded as the optimal approach to lymph node assessment in patients with pancreatic cancer. On the other hand, lymph node metastases do not preclude pancreatic resection, so their presence is not as important for the surgeon as vessel infiltration.
Assessment of resectability Abdominal ultrasonography allows not only surgeons but also general practitioners to establish a correct diagnosis. When performed by experienced sonographers, abdominal ultrasonography may predict the type of surgical treatment with an accuracy of 74.8%. The accuracy for detection of major artery involvement (the superior mesenteric artery or celiac axis) was even higher-81.7%. The most crucial factor affecting resectability of pancreatic cancer is infiltration of the superior mesenteric artery or celiac axis or both (described as category T4 in the TNM classification). Currently, the gold standard for evaluating resectability of pancreatic tumors remains the intraoperative assessment of tumor advancement by the surgeon, particularly with regard to major vessel infiltration. However, in
The greatest difficulty in assessing the stage of pancreatic tumor by ultrasound imaging is associated with the identification of extrapancreatic tumor extension (cT3) and vascular invasion (cT4). Thus, the diagnostic accuracy decreases with a higher T category. This phenomenon was observed in other studies on abdominal ultrasonography. Dabizzi et al., 9 showed that the sensitivity of ultrasonography in detecting pancreatic tumors can reach 95%, which is consistent with the results of our study. In addition, Michl et al. 10 demonstrated that ultrasonography may have similar sensitivity to that of CT for detecting small lesions (<2 cm, cT1), especially when advanced imaging techniques are used. Karlson et al., 6 in a study on 919 consecutive patients undergoing pancreatic ultrasonography, reported a specificity of ultrasonography for the detection of pancreatic carcinoma to be 90%. A high accuracy of ultrasonography for pancreatic cancer (95.9%) was reported by Tanaka et al. 11 in a study on 51 patients with confirmed pancreatic malignancy. In 8% of the patients, a tumor diameter of less than 1 cm was observed on ultrasonography. A lower accuracy of abdominal ultrasonography (89%) for diagnosing malignant tumors in the head of the pancreas was reported by Grossjohann et al. 12 This study included only 49 patients and was conducted by radiologists who did not verify their findings intraoperatively. The diagnostic accuracy of ultrasonography in assessing arterial invasion (cT4) was lower in previous articles-it was up to 90% when power Doppler imaging was used.
13 In another study, Trede et al. reported the accuracy of MRI in assessing the T category of pancreatic cancer to be from 88% to 91%. The above results indicate that abdominal ultrasonography performed by an experienced sonographer allows to assess the stage of pancreatic cancer, although the results are not as reliable and accurate as those obtained by CT or MRI.
The overall diagnostic accuracy of abdominal ultrasonography in 454 patients analyzed in our study was established at 85.6%. Based on the previously published reports, the accuracy of abdominal ultrasonography in detecting pancreatic tumors ranges between 75% and 95%. 5, 13, [19] [20] [21] [22] [23] [24] [25] Our results show that the efficacy of ultrasound examination in detecting pancreatic cancer is only slightly lower than that of other imaging methods such as MRI or 64 -slice multi detector row CT the majority of our patients, pancreaticoduodenectomy had not been performed in the case of major vessel infiltration.
Based on the obtained results, it might be concluded that the preoperative ultrasound examination is a relatively valuable method for predicting the type of surgery in patients with pancreatic cancer. Less favorable results were reported by American scientists who evaluated the accuracy of abdominal ultrasonography for assessing vascular infiltration by pancreatic cancer to be merely 60%. 33 Other studies reported a higher accuracy of abdominal ultrasonography, reaching 80% to 96% when the color Doppler mode was used.
7,9,31 Minniti et al. 21 reported the accuracy of ultrasonography to be 81.4%, which was lower than that of CT (86%). The advancement in surgical techniques has enabled to use resection for more advanced pancreatic tumors. The diagnosis of such borderline resectable tumor requires the use of CT to obtain reliable information on vascular invasion. Therefore, CT should be performed in each patient with pancreatic cancer before any decisions on treatment.
Conclusions Despite the use of new diagnostic imaging techniques, pancreatic cancer remains one of the leading causes of death from cancer, and the overall 5 -year survival rate is 5% or lower.
34 The results of our study summarize 12 years of our own experience with abdominal ultrasonography and suggest that ultrasound examination still remains a valuable diagnostic modality in patients with pancreatic cancer. This examination should be recommended not only by general practitioners suspecting pancreatic malignancy but also by surgeons as the first -line diagnostic procedure in patients with pancreatic cancer. Abdominal ultrasonography is useful in recognizing metastatic disease when resection is contraindicated, in clinical staging (T category), and in predicting resectability. Moreover, when both pancreatic tumor and distant metastases are found on ultrasonography, there is no need to assess resectability by CT as the treatment starts with chemotherapy. Ultrasonography also remains a useful tool to confirm pancreatic carcinoma by fine -needle aspiration biopsy, which is obligatory before starting chemotherapy. Further research on preoperative staging of pancreatic cancer is needed to evaluate the diagnostic value of other options available in ultrasound imaging such as contrast -enhanced examination, harmonic imaging, cross -beam, or sonoelastography.
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